Advancing breakthroughs for the treatment of thyroid autoimmune diseases
Yarrow Bioscience is a new company focused on developing a first-in-class anti-TSHR antibody for Graves’ disease and thyroid eye disease.
Yarrow Bioscience is a new company focused on developing a first-in-class anti-TSHR antibody for Graves’ disease and thyroid eye disease.